Efficacy and safety of paclitaxel/ramucirumab as the second-line chemotherapy in Japanese patients with advanced gastric cancer.

被引：1
|
作者：
Kusumoto, Tetsuya
Egashira, Akinori
Sonoda, Hideto
Hashimoto, Kenkichi
Uehara, Hideo
Kusumoto, Eiji
Shinzato, Chiaki
Uchino, Keita
Sakaguchi, Yoshihisa
Ikejiri, Koji
Maehara, Yoshihiko
机构：
[1] Natl Kyushu Med Ctr, Dept Gastrointestinal Surg, Fukuoka, Fukuoka, Japan
[2] Natl Kyushu Med Ctr, Clin Res Ctr Canc Res Div, Fukuoka, Fukuoka, Japan
[3] Natl Kyusyu Med Ctr, Dept Med Oncol, Fukuoka, Fukuoka, Japan
[4] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Fukuoka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15540
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15540
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Paclitaxel combined with ramucirumab as the second-line chemotherapy for elderly patients with advanced gastric cancer.
    Kusumoto, Tetsuya
    Uehara, Hideo
    Hashimoto, Kenkichi
    Fujinaka, Yoshihiko
    Yoshinaga, Keiji
    Kusumoto, Eiji
    Shinzato, Chiaki
    Sakaguchi, Yoshihisa
    Ikejiri, Koji
    Maehara, Yoshihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Weekly Paclitaxel as Second-line Chemotherapy in Japanese Patients with Advanced Gastric Cancer
    Kadokura, Makoto
    Iwasa, Satoru
    Honma, Yoshitaka
    Kato, Ken
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Enomoto, Nobuyuki
    Shimada, Yasuhiro
    ANTICANCER RESEARCH, 2013, 33 (10) : 4547 - 4552
  • [3] Efficacy and safety of nab-paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment for patients with advanced gastric cancer: A single institutional experience
    Okunaka, Mashiro
    Kotani, Daisuke
    Demachi, Ken
    Kawazoe, Akihito
    Yoshino, Takayuki
    Shitara, Kohei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [4] Second-line chemotherapy with paclitaxel for elderly patients with advanced gastric cancer
    Ohba, Akihiro
    Takashima, Atsuo
    Nishiuchi, Takamasa
    Honma, Yoshitaka
    Iwasa, Satoru
    Okita, Natsuko
    Kato, Ken
    Hamaguchi, Tetsuya
    Nagashima, Kengo
    Boku, Narikazu
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [5] Ramucirumab Plus Paclitaxel as a Second-line Chemotherapy in Older Adults With Advanced Gastric Cancer (YCOG1601)
    Sato, Sho
    Kunisaki, Chikara
    Tamura, Yuko
    Yago, Akikazu
    Kasahara, Kohei
    Sato, Tsutomu
    Kondo, Hiroki
    Kosaka, Takashi
    Akiyama, Hirotoshi
    Endo, Itaru
    ANTICANCER RESEARCH, 2023, 43 (12) : 5663 - 5669
  • [6] Optimal indications for second-line chemotherapy in advanced gastric cancer.
    Hasegawa, Hiroko
    Fujitani, Kazumasa
    Nakazuru, Shoichi
    Hirao, Motohiro
    Mita, Eiji
    Tsujinaka, Toshimasa
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [7] Weekly paclitaxel as second-line chemotherapy for advanced or recurrent gastric cancer
    Hironaka S.
    Zenda S.
    Boku N.
    Fukutomi A.
    Yoshino T.
    Onozawa Y.
    Gastric Cancer, 2006, 9 (1) : 14 - 18
  • [8] Second-line chemotherapy for patients with advanced gastric cancer
    Daisuke Takahari
    Gastric Cancer, 2017, 20 : 395 - 406
  • [9] Second-line chemotherapy for patients with advanced gastric cancer
    Takahari, Daisuke
    GASTRIC CANCER, 2017, 20 (03) : 395 - 406
  • [10] The role of ramucirumab plus paclitaxel as second-line therapy after failure of nivolumab plus doublet chemotherapy in patients with advanced gastric cancer
    Jeon, Youngkyung
    Lim, Sung Hee
    Lee, Jeeyun
    Kang, Won Ki
    Jang, Jae Yeon
    Jeong, Sun Young
    Choi, Daeho
    Kim, Seung Tae
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (06) : 2346 - 2353
12345